CPT II deficiency is classified as a Secondary Condition in the Recommended Uniform Screening Panel (RUSP) in the United States of America [8] however, based on the high sensitivity and specificity in our experience, we suggest that it should be considered for addition as a primary target on newborn screening panels. Here, CPT2 is linked to hyperinsulinemic hypoglycemia, familial, 4.